Hydroxyurea-Induced miRNA Expression in Sickle Cell Disease Patients in Africa

Hydroxyurea (HU) is clinically beneficial in sickle cell disease (SCD) through fetal hemoglobin (HbF) induction; however, the mechanism of HU is not yet fully elucidated. Selected miRNAs have been associated with HU-induced HbF production. We have investigated differential HU-induced global miRNA ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Mnika, Khuthala, Mazandu, Gaston K., Jonas, Mario, Pule, Gift D., Chimusa, Emile R., Hanchard, Neil A., Wonkam, Ambroise
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6568309/
https://www.ncbi.nlm.nih.gov/pubmed/31231425
http://dx.doi.org/10.3389/fgene.2019.00509

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6568309/
https://www.ncbi.nlm.nih.gov/pubmed/31231425
http://dx.doi.org/10.3389/fgene.2019.00509

Ejemplares similares